Dėl vakcinos nuo meningokoko B kompensavimo


Svečias

/ #575 UK kaina £20 per dose

2016-03-07 16:16

GSK finally seals U.K. Bexsero deal for £20 per dose, report says

March 30, 2015 | By Eric Sagonowsky
 
 
U.K. Health Secretary Jeremy Hunt

The deal's done: Less than a month after receiving Novartis' stall of vaccines products, GlaxoSmithKline has ended the yearlong pricing standoff with the United Kingdom's National Health Service over meningitis B vaccine Bexsero.

For £20 per dose, Bexsero will be added to the country's national immunization schedule, enabling the annual protection of 800,000 babies at a cost of £16 million, the Daily Mail reports. Britain will become the first country in the world with a nationwide meningitis vaccine program, Health Secretary Jeremy Hunt said, according to The Guardian.